Last reviewed · How we verify
Arilat (carbaryl)
Arilat (generic name: carbaryl) is a drug. It is currently in unknown development.
Carbaryl works by inhibiting acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine, leading to overstimulation of nerve cells.
Carbaryl is a small molecule insecticide with the chemical formula C10H7OC(O)NHCH3, classified as a carbamate. It is a white solid sold under the brand name Sevin, which was a trademark of the Bayer Company.
At a glance
| Generic name | carbaryl |
|---|---|
| Target | Ace-orthologous acetylcholinesterase; Acetylcholinesterase, Acetylcholinesterase |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Think of it like a stuck record: acetylcholine is a chemical messenger that helps nerves communicate. When carbaryl blocks the enzyme that breaks down acetylcholine, the nerve cells get overwhelmed with too many messages, ultimately paralyzing the insect or rodent.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Arilat CI brief — competitive landscape report
- Arilat updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Arilat
What is Arilat?
How does Arilat work?
What is the generic name of Arilat?
What development phase is Arilat in?
What does Arilat target?
Related
- Target: All drugs targeting Ace-orthologous acetylcholinesterase; Acetylcholinesterase, Acetylcholinesterase
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing